Drugs for GI Disorders Flashcards
The most common secretory disorder in GI tract is
acid- peptic disease
- peptic ulcer disease
- GERD (50%)
- hypersecretory states (Zollinger ellison syndrome)
Goals of treating acid-peptic disease
Relieve pain, promote healing, prevent recurrence
Anti ulcer drugs act to
neutralize gastric acid, reduce secretion, enhance mucosal defenses
Anti muscarinic drugs for gastric acid secretion
weak inhibitors of acid secretion because they act at one site
-Ach mediator acting on muscarinic receptors
Use with other therapies
Gastrin blockage
-peptide hormones formed by mucosal cells
Stimulates gastric motility, HCL, and pepsin secretion
Acts towards gastrin- cholecystokinin B and is an H2 blocker
H2 antagonists (general)
reduce gastrin secretion by blocking histamine induced inc cAMP and proton pump activation (Gastric acid secretion)
On parietal cell
PPI
-end with -prazole (omeprazole, esomeprazole, etc.)
Benzimidazole cpds irreversibly inhibit parietal cell proton pump, H/K/ATPase
Prodrugs which are inactive at neutral pH- requires acidic environment in canaliculi (don’t give with antacids)
Metabolized in liver
More effective than H2 antagonists or NSAID induced peptic ulcers
AE of PPI
GI effects because no longer having acidic environment to prevent food and microbes from entering small bowel
Diarrhea with prolonged use due to GIT bacterial overgrowth
Activation of PPI
Prodrugs which after passing through stomach, enteric coating dissolve and the pro drug is absorbed in the intestines and then carried to parietal cell, where drug accumulates in secretory canaliculi.
Here, the activated drug binds to sulfyhdryl groups on H/K ATPase
H2 antagonists-
-end with tidine (famotidine > nizatidine = ranitidine > cimetidine)
histamine (H2) receptor antagonists to reduce gastric acid and pepsin secretion (particularly useful at bedtime)- does not inhibit other receptors or channels
inhibit acid secretion for <6 hrs when OTC and inhibits 60-70% for 24 hours when prescription
decline use because of ppi
do not use in combo with ppis because reduce acid secretion in parietal cells so ppi won’t get activated
H2 Antagonist AE
- safe
- not to be given to pregnant women bc they cross placenta and secreted into breast milk
- diarrhea, headaches, bradycardia, fatigue
- confusion and agitation with IV admin in pts who are elderly
Cimetidine
H2 receptor antagonist which causes gynecomastia or impotence in men and galactorrhea in women because endocrine effects (cimetidine inh binding of dihydrotestosterone to androgen receptors)
interferes with cyp 450 pathways
Antacids
- aluminum hydroxide, calcium carbonate, combination aluminum hydroxide and magnesium hydroxide (aluminum will lead to constipation, magnesium will lead to diarrhea, calcium is constipating)
- weak bases that neutralize gastric Hcl
- used as needed to relieve pain in esophagitis, peptic ulcer, and GERD
can cause cation absorption and systemic alkalosis in renal pts
Do not use antacids if you are a
renal pt- can cause cation absorption and systemic alkalosis in renal pts
-Sucralfate (aluminum sucrose sulfate)
- Mucosal protective agent
- protective coating on peptic ulcers
require’s acidic environment to be activated
AE: constipation
few other adverse effects